Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma
Rapa Therapeutics LLC
Rapa Therapeutics LLC
National Institutes of Health Clinical Center (CC)
Biocon Limited
Duke University
Bristol-Myers Squibb
Peking University Cancer Hospital & Institute
M.D. Anderson Cancer Center
University Hospital, Grenoble
Kaiser Permanente
OHSU Knight Cancer Institute
Qingdao Sino-Cell Biomedicine Co., Ltd.
Indiana University
Nantes University Hospital
Institute of Health Information and Statistics of the Czech Republic
Second Life Therapeutics
Onchilles Pharma Inc
UNICANCER
McMaster University
Ohio State University Comprehensive Cancer Center